Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02423954 | Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)(NivoPlus) | terminated | Phase 1 / Phase 2 | 33 | Western Regional Medical CenterOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02566421 | Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery | terminated | N/A | 110 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 |
| clinicaltrials |
| NCT01159964 | Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery | terminated | Phase 1 | 60 | GlaxoSmithKlineINDUSTRY | 6 | Jun 18, 2018 | clinicaltrials |
| NCT00955305 | Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | terminated | Phase 2 | 175 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02252796 | Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer(HySBst) | terminated | Phase 1 | 1 | West Virginia UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT01607554 | Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 2 | New Mexico Cancer Research AllianceOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT02543645 | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | terminated | Phase 1 | 18 | Celldex TherapeuticsINDUSTRY | 1 | Apr 30, 2018 | clinicaltrials |
| NCT00901537 | Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer | terminated | Phase 1 | 8 | Loma Linda UniversityOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01188486 | Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | terminated | N/A | 12 | Stanford UniversityOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT00281021 | Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer | terminated | Phase 2 | 26 | University of LouisvilleOTHER | 0 | Mar 29, 2018 | clinicaltrials |
| NCT00449657 | Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC | terminated | Phase 2 | 24 | Leo W. Jenkins Cancer CenterOTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT00096265 | Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer | terminated | Phase 3 | 126 | National Cancer Institute (NCI)NIH | 2 | Mar 9, 2018 | clinicaltrials |
| NCT00265200 | Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer | terminated | Phase 2 | 28 | University of LouisvilleOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT00268151 | Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer | terminated | Phase 1 | 24 | University of LouisvilleOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT01426620 | Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer(BIT-2) | terminated | Phase 2 | 4 | University of LouisvilleOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT02491775 | Afatinib Genomic Landscape | terminated | — | 6 | Washington University School of MedicineOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT02554591 | Genomic Landscape of Ceritinib | terminated | — | 6 | Washington University School of MedicineOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT02590003 | Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer | terminated | Phase 2 | 3 | Yale UniversityOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT02342353 | Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) | terminated | Phase 1 | 8 | Washington University School of MedicineOTHER | 1 | Feb 27, 2018 | clinicaltrials |
| NCT01090830 | Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer(HCH003) | terminated | Phase 1 / Phase 2 | 7 | Holy Cross Hospital, FloridaOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT02119650 | Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer | terminated | Phase 2 | 76 | Incyte CorporationINDUSTRY | 1 | Feb 13, 2018 | clinicaltrials |
| NCT03053297 | Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)(PANORAMA) | terminated | — | 89 | AstraZenecaINDUSTRY | 6 | Feb 8, 2018 | clinicaltrials |
| NCT02393209 | Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 14 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Feb 7, 2018 | clinicaltrials |
| NCT00681512 | The Effect of Berries on Lung Cancer Tumors | terminated | N/A | 6 | University of LouisvilleOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT00003497 | Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02134015 | Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)(HER3-Lung) | terminated | Phase 3 | 145 | Daiichi SankyoINDUSTRY | 10 | Jan 23, 2018 | clinicaltrials |
| NCT02326285 | Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB(NeoIntercal) | terminated | Phase 2 / Phase 3 | 1 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01574222 | A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer(VTNSCLC) | terminated | Phase 1 | 1 | VA Office of Research and DevelopmentFED | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02018523 | Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer | terminated | Phase 1 | 7 | Jun ZhangOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02919462 | Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression(HighTySy) | terminated | Phase 2 | 2 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01419587 | Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG) | terminated | N/A | 11 | University of IowaOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT00369070 | A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC | terminated | Phase 2 | 186 | AmgenINDUSTRY | 0 | Jan 4, 2018 | clinicaltrials |
| NCT01797471 | Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer | terminated | N/A | 1 | University of MiamiOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT02336061 | Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer(IMPULSO) | terminated | — | 344 | Asociación para la Investigación del Cáncer de Pulmón en MujeresOTHER | 1 | Dec 15, 2017 | clinicaltrials |
| NCT00794547 | Phase I/II Calcitriol in Lung Cancer | terminated | Phase 1 / Phase 2 | 34 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01511081 | Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | terminated | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT01342770 | Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2017 | clinicaltrials |
| NCT01746810 | IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors | terminated | Phase 1 | 1 | New Mexico Cancer Research AllianceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00932152 | Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer | terminated | Phase 2 | 3 | University of PittsburghOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT01065818 | Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET | terminated | N/A | 6 | Columbia UniversityOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT02695290 | Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) | terminated | Phase 4 | 1 | Boehringer IngelheimINDUSTRY | 1 | Sep 18, 2017 | clinicaltrials |
| NCT00881712 | Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)(LU02) | terminated | N/A | 15 | University of FloridaOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT02121899 | Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)(ONC006) | terminated | — | 44 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02121925 | Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up(ONC003) | terminated | — | 227 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02538627 | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib | terminated | Phase 1 | 5 | Merrimack PharmaceuticalsINDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02049151 | Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer(START2) | terminated | Phase 3 | 35 | EMD SeronoINDUSTRY | 2 | Aug 23, 2017 | clinicaltrials |
| NCT02835599 | Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now(REVOLUTION) | terminated | — | 23 | AstraZenecaINDUSTRY | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02715102 | Circulating Tumor DNA in Patients at High Risk for Lung Cancer | terminated | — | 39 | Pathway GenomicsINDUSTRY | 1 | Aug 21, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 2, 2018source: clinicaltrials